Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |